SeraCare Life Sciences (SRLS) Posts Q4 GAAP Loss of 4c/Share

November 17, 2011 7:05 AM EST
SeraCare Life Sciences, Inc. (NASDAQ: SRLS) reported Q4 GAAP loss of ($0.04), which may not compare with the analyst estimate of $0.02. Revenue for the quarter came in at $10.99 million versus the consensus estimate of $10.95 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings